As of Oct 26, 2026: Vanda Pharmaceuticals (VNDA) has a PDUFA date for imsidolimab on Dec 12, 2026, in 47 days. Its Quality Score is -9. Scores as of 9:21 PM ET, 15 minutes behind.

VNDA FDA decision on Imsidolimab

Vanda Pharmaceuticals · PDUFA date

PDUFA dateDec 12in 47 days Quality Score-9Poor

Cash runway4quarters of cash

What the company said

“PDUFA target action date of December 12, 2026”

PDUFA date, Dec 12, 2026. As Vanda Pharmaceuticals stated in its 8-K of Aug 5, 2026 (the filing).

A PDUFA date is the day the FDA has said it aims to decide on a drug. The FDA can decide earlier, or extend its review, often by three months.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Get an alert before VNDA's FDA date

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

How VNDA's stock moved on its past FDA days, for Pro members. Pro members also see whether its cash lasts past Dec 12, and the members' FDA calendar with filters and optional alerts.

More on VNDA and the FDA calendar

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

The FDA calendar.